Status:
UNKNOWN
Respiratory Aerosols in Patients With COVID-19 and Healthy Controls
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Collaborating Sponsors:
Palas GmbH
Conditions:
SARS-CoV-2 Infection
Covid19
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The proposed study will investigate respiratory aerosols in SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2) positive and negative children and adults with the Resp-Aer-Meter (Palas GmbH)...
Detailed Description
Corona virus disease 2019 (COVID-19) is a viral illness caused by SARS-CoV-2. Current research suggests that the SARS-CoV-2 infection is primarily spread through droplets and aerosols. As per current ...
Eligibility Criteria
Inclusion
- Age 6 years or older
- SARS-CoV-2 PCR testing within the last 3 days
- Ability to capture extend and consequences of the study
- Written informed consent of patient and, if applicable, of caregiver
Exclusion
- Age under 6 years
- Inability to participate in aerosol measurement
- Inability to participate in Spirometry
- Inability to capture extend and consequences of the study
- Only for arm 1 (PCR SARS-CoV-2 negative adults): chronic disease with immunosuppressive therapy
Key Trial Info
Start Date :
January 18 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
525 Patients enrolled
Trial Details
Trial ID
NCT04739020
Start Date
January 18 2021
End Date
December 31 2021
Last Update
December 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johann Wolfgang Goethe University Hospital
Frankfurt am Main, Hesse, Germany, 60590